Hormonal & EndocrineResearch OnlyS

Ovagen

Ovarian Bioregulator

Investigational peptide-bioregulator discussed for ovarian/endocrine pathways.

XRedditFacebook
Observational report only — live community data. Not medical advice. Does not recommend doses, protocols, or treatments.
Studies cited
3
Research grade
S
Community score
168

Trend index

Trackers
3,310

Overview

About Ovagen

Investigational peptide-bioregulator discussed for ovarian/endocrine pathways.

Category
Hormonal & Endocrine
Regulatory status
Research Only
Also known as
Ovarian Bioregulator
Self-reports
6

Community

What 6 users report

6 community reports

Positive 0% · Neutral 50% · Negative 50%

Most reported benefits

Libido
6
Recovery
3

Dose distribution

Median: 2000+ mcg · Most common: 2000+ mcg

0–25
0
25–50
0
50–100
0
100–200
0
200–400
0
400–600
0
600–1000
0
1000–2000
0
2000+
6

Commonly stacked with

Research

Cited research (2)

Help

Frequently asked

What do PeptIQ users report about Ovagen?

This page summarizes 6 anonymized self-reports from PeptIQ users who track Ovagen, including commonly reported effects and co-tracked peptides. These are observational patterns, not clinical outcomes.

What research is cited for Ovagen?

2 sources are linked on this page, including PubMed articles, clinical trial registries, and FDA labels where applicable. Citations describe published research — not recommendations.

Is Ovagen safe to use?

This wiki does not assess safety or recommend use. Ovagen is listed as Research Only. Consult a licensed clinician for personal medical decisions.

What are the purported benefits and uses of Ovagen?

Research, primarily in animal models, suggests Ovagen may have a wide range of therapeutic potentials due to its ability to promote angiogenesis (formation of new blood vessels), stimulate collagen synthesis, and modulate inflammatory responses.

Source

What is the legal status of Ovagen?

Ovagen is not approved by the FDA for any human use. There is no legal basis for selling it as a drug, food, or dietary supplement in the United States. The FDA has classified Ovagen as a Category 2 bulk drug substance, which explicitly prohibits licensed compounding pharmacies from using it in compounded medications.

Source

What are the known or theoretical side effects and risks of Ovagen?

The safety and effectiveness of Ovagen have not been thoroughly evaluated in humans through rigorous clinical trials. This lack of human data means that safe dosages, short-term side effects, and long-term health consequences are largely unknown.

Source

What is the current state of research on Ovagen?

While there are over 200 published studies on Ovagen, the vast majority are animal or in vitro (cell) studies. These preclinical studies consistently show positive results across various tissue types. However, there is a significant lack of comprehensive human clinical trial data.

Source